Lemaitre Vascular (LMAT) Free Cash Flow Growth (3y) (2013 - 2026)
Lemaitre Vascular (LMAT) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 65.83% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 414.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 27.06% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.44% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 23.97% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -3.97% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -37.68% |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | 335.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 335.54% |
| Dec 31, 2025 | 96.52% |
| Sep 30, 2025 | 56.71% |
| Jun 30, 2025 | 31.81% |
| Mar 31, 2025 | 22.40% |
| Dec 31, 2024 | 43.46% |
| Sep 30, 2024 | 0.85% |
| Jun 30, 2024 | -3.02% |
| Mar 31, 2024 | -9.63% |
| Dec 31, 2023 | -9.89% |
| Sep 30, 2023 | -7.30% |
| Jun 30, 2023 | 21.80% |
| Mar 31, 2023 | -22.97% |
| Dec 31, 2022 | -12.42% |
| Sep 30, 2022 | 22.32% |
| Jun 30, 2022 | 33.41% |
| Mar 31, 2022 | 82.61% |
| Dec 31, 2021 | -5.55% |
| Sep 30, 2021 | 48.11% |
| Jun 30, 2021 | 27.76% |